Delivery Order SPE2DB20D1100-SPE2DB25FE6B8
Award Date 9/11/25
Potential Completion Date 9/12/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,242.06 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 MCG inhalers (12-gram units) on August 18, 2025, with completion scheduled for August 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency awarded a delivery order valued at $4,086.68 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 mcg inhalers (12 gram units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,075.75 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This non-set-aside contract was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and operates under firm fixed price terms. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,817.34 on August 19, 2025, for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12 grams). This contract represents a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Fluticasone Propionate HFA 110 MCG inhalers in 12-gram quantities. This competitively awarded, non-set-aside contract has a ceiling value of $1,108.08 with a firm fixed price and an ultimate completion date of August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the primary contractor for this delivery order under its...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This is a firm fixed-price, non-set-aside contract with a ceiling value of $1,051.91 and an ultimate completion date of August 15, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,032.60 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in a 12-gram inhaler on August 28, 2025, with final completion scheduled for August 29, 2025. This firm fixed-price delivery order was awarded without set-aside designation through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Fluticasone Propionate HFA 220 micrograms in 12-gram inhalers, valued at $1,725.32. This firm fixed-price delivery order, which is not set-aside and therefore awarded through open competition, has an ultimate completion date of September 10, 2025. The award represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Fluticasone Propionate HFA 44 mcg 10.6gm inhalers, valued at $1,257.22. This is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a contract value of $24,494.88 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...